Huntsman Cancer Institute/The University of Utah — Salt Lake City, Utah

Huntsman Cancer Institute/The University of Utah is a clinical research site located in Salt Lake City, Utah, United States 84112.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Huntsman Cancer Institute/The University of Utah has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Sponsors: Epizyme, Inc., Elios Therapeutics, LLC, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salt Lake City

Browse all research sites in Utah · View every site in Salt Lake City

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Huntsman Cancer Institute/The University of Utah?

Huntsman Cancer Institute/The University of Utah has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Huntsman Cancer Institute/The University of Utah conducted?

Huntsman Cancer Institute/The University of Utah has 3 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Is Huntsman Cancer Institute/The University of Utah accredited by Crixeo Clinical Trials?

Huntsman Cancer Institute/The University of Utah has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Huntsman Cancer Institute/The University of Utah?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.